ANTIVIRAL TECHNOLOGIES, INC.
CIK 0001445226
Revenue (TTM)
—
Q3 Sep 2014
Net Income (TTM)
−$352.38K
−3.5% YoY
Q3 Sep 2014
EPS Diluted (TTM)
—
Q3 Sep 2014
Gross Margin
—
Q3 Sep 2014
Operating Margin
—
Q3 Sep 2014
Net Margin
—
Q3 Sep 2014
Free Cash Flow (TTM)
—
Q3 Sep 2014
Cash
$4.04K
Q3 Sep 2014
Total Debt
—
Q3 Sep 2014
Shares Outstanding
150M sh
Q3 Sep 2014
Revenue & Net Income
Cash Flow
Revenue Growth (YoY)
No data available for this metric.